Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.24.3
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Concentration Risk [Line Items]        
Revenues $ 88,834 $ 83,967 $ 255,624 $ 239,764
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 56,506 58,354 166,730 171,887
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 32,328 $ 25,613 $ 88,894 $ 67,877